Skip to content

Blunt Fascial vs. Veress Needle Peritoneal Entry in Laparoscopic Gynecologic Surgery

Blunt Fascial vs. Veress Needle Peritoneal Entry in Laparoscopic Gynecologic Surgery: A Randomized Controlled Trial

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06305975
Acronym
BluntFascial
Enrollment
100
Registered
2024-03-12
Start date
2024-03-22
Completion date
2025-03-01
Last updated
2024-05-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Laparoscopic Surgery

Keywords

Abdominal entry, Laparoscopy, Insufflation time, Postoperative pain, Safety

Brief summary

This study aims to investigate the effect of two peritoneal entry techniques on intraoperative and post-operative outcomes among patients undergoing laparoscopic surgery with a minimally invasive gynecologic surgeon. Patients will be randomized to either blunt fascial or veress needle peritoneal entry. Insufflation times, failed entries, complications and post-operative pain scores will be collected. The investigators hypothesize that the blunt entry technique will be associated with shorter insufflation times and similar intraoperative and postoperative outcomes compared with the veress needle entry technique. Primary Objective: To evaluate the insufflation times and success upon peritoneal entry according to peritoneal entry technique. Secondary Objectives: To evaluate the surgical outcomes and patients pain scores according to peritoneal entry technique.

Detailed description

This will be a single-center, single-blinded randomized controlled trial evaluating the impact of peritoneal entry technique on insufflation times, entry failure, post-operative pain and surgical outcomes among patients undergoing laparoscopic gynecologic surgery. The investigators hypothesize that the blunt fascial entry technique will be associated with shorter insufflation times with no effect on other surgical outcomes. The study will include 2 groups corresponding to the entry techniques: blunt facial entry and Veress needle entry. Participants will be 1:1 allocated to each technique by block randomization. Blunt fascial entry technique description: a 5 mm incision is made in the umbilicus. Next, a curved Kelly forceps is used to open the fascia, and, if possible, the peritoneum. The Kelly forceps are then used to expand the opening to a 10 mm diameter. A 5 mm trocar is placed into the fascial hole and used to quickly insufflate the abdomen to 15 mm Hg. Once the abdomen is fully insufflated, a 10 mm trocar is placed using optical guidance.

Interventions

PROCEDUREBlunt fascial abdominal entry

Blunt fascial entry technique description: a 5 mm incision is made in the umbilicus. Next, a curved Kelly forceps is used to open the fascia, and, if possible, the peritoneum. The Kelly forceps are then used to expand the opening to a 10 mm diameter. A 5 mm trocar is placed into the fascial hole and used to quickly insufflate the abdomen to 15 mm Hg. Once the abdomen is fully insufflated, a 10 mm trocar is placed using optical guidance.

PROCEDUREVeress needle abdominal entry

Veress needle abdominal entry technique description: a 5 mm incision is made in the umbilicus. Next, a Veress needle is used to enter the peritoneal cavity and inflate the abdomen to 15 mm Hg. Once the abdomen is fully insufflated, a 10 mm trocar is placed using optical guidance.

Sponsors

Cedars-Sinai Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1. Provision of signed and dated informed consent form 2. Stated willingness to comply with all study procedures and availability for the duration of the study 3. 18 years of age or older 4. Undergoing conventional laparoscopic surgery at Cedars-Sinai Medical Center with a surgeon in the Minimally Invasive Gynecologic Surgery division.

Exclusion criteria

1. Pregnancy 2. Urgent/non-scheduled surgery 3. Non-eligible for umbilical entry

Design outcomes

Primary

MeasureTime frameDescription
Insufflation timeIntraoperativeThe time it takes to insufflate the abdominal cavity to 15 mm Hg.
Success upon peritoneal entryIntraoperativeSuccessful abdominal entry in the first trial

Secondary

MeasureTime frameDescription
Patients pain scoresDay of surgery, postoperatively and before discharge* First reported pain score in PACU using the numerical rating scale (0-10). * Last reported pain score in PACU prior to discharge using the numerical rating scale (0-10).
Intraoperative complicationsIntraoperative\- Intraoperative complications upon peritoneal entry
Length of hospital stayDay of surgery, postoperatively and before discharge. In rare cases, hospital stay will be longer than one day.\- Length of stay- from arrival to PACU to discharge home)
Analgesics useDay of surgery, postoperatively and before discharge\- Total analgesic requirements in PACU
Postoperative complicationsPostoperative period within 30 days of surgeryAny postoperative complications

Countries

United States

Contacts

Primary ContactRaanan Meyer, MD
Raanan.Meyer@cshs.org3104234073
Backup ContactKacey Hamilton
3104234073

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026